Clinical trial
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered…
NCT00262028 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00262028 |
|---|---|
| Title | Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children |
| Official title | A Phase 2, Randomized, Single-blind, Controlled, Single-Center Study to Compare the Safety and Immunogenicity of One Dose of Chiron Meningococcal ACWY Conjugate Vaccine With One Dose of Licensed Meningococcal ACWY Polysaccharide Vaccine Administered to Healthy Children 2-10 Years of Age and an… |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prevention of Meningococcal Disease |
| Intervention type | Biological |
| Interventions | MenACWY-CRM Vaccine, MenACWY-PS Vaccine |
| Enrollment | 910 |
| Start date | Apr 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 6, 2005 |
| Last update posted | Feb 11, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: